Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 5, 2026

Fast Food & Quick Service Restaurants Strategic Business Market Report 2026

View original at globenewswire.com
Fast Food & Quick Service Restaurants Strategic Business Market Report 2026 Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Fast Food & Quick Service Restaurants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Independent Restaurants segment is expected to reach US$245.8 Billion by 2030 with a CAGR of 3%

    80% confidence
  • The global market for Fast Food & Quick Service Restaurants was valued at US$316.1 Billion in 2024 and is projected to reach US$384 Billion by 2030, growing at a CAGR of 3.3% from 2024 to 2030

    80% confidence
  • Technology is revolutionizing the fast food and QSR industry by enhancing customer experience, streamlining operations, and improving service efficiency

    80% confidence
  • The Chain Restaurants segment is set to grow at 3.8% CAGR over the analysis period

    80% confidence
  • U.S. market valued at $85.3 Billion in 2024, and China forecasted to grow at an impressive 6.3% CAGR to reach $78.9 Billion by 2030

    80% confidence
  • The demand for fast food and quick service restaurants (QSRs) is steadily rising due to changing consumer lifestyles, urbanization, and a growing preference for convenience

    80% confidence
  • As health-consciousness rises globally, fast food and QSRs are adapting their offerings to align with consumers' focus on wellness and balanced nutrition

    80% confidence
  • The growth in the fast food and quick service restaurant market is driven by a combination of convenience, technological innovation, evolving consumer preferences, and global expansion

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com